financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
Mar 4, 2024 11:01 PM

01:00 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target to $71 from $47 on a P/S of 7.5x, above its three-year average on good sales execution and a favorable deal pipeline, using our next-12-month sales estimate of $2.3B. We lift our FY 24 EPS view to $1.07 from $0.95 and FY 25's to $1.33 from $1.21. NTNX posted Q2 sales of $565.2M, above consensus by $14.8M, while non-GAAP EPS of $0.46 beat by $0.17. Revenue rose 16.2% Y/Y from solid Subscription revenue growth (+18% Y/Y) as ACV billings outperformed, up 23% Y/Y, from higher-than-anticipated renewals. We note NTNX's commentary around a continued uncertain macro environment, and longer average sales cycles, which likely impacted contract duration of 2.8 years in Q2, lower than Q1. However, these results reflect the firm's strong execution in securing and keeping pace with renewals and expansion deals, as well as maintaining healthy pricing levels in spite of these challenges. Its upbeat guidance and a higher mix of large deals in the pipeline further support our positive view of the business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Retains Sell Opinion On Shares Of 10x Genomics, Inc.
Research Alert: CFRA Retains Sell Opinion On Shares Of 10x Genomics, Inc.
May 26, 2025
12:50 AM EDT, 05/12/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our target price at $7, based on our DCF analysis. We narrow our 2025 adjusted LPS view to -$0.56 from -$1.50 and our 2026 adjusted LPS estimate to...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Amcor Plc
Research Alert: CFRA Maintains Hold Opinion On Shares Of Amcor Plc
May 26, 2025
02:00 PM EDT, 05/12/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $1 to $11, valuing AMCR at an EV/EBITDA of 9.2x our FY 26 EBITDA estimate, a discount to the weighted average (63% AMCR ownership...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Franklin Resources, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Franklin Resources, Inc.
May 26, 2025
02:55 AM EDT, 05/12/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our 12-month target price of $22, valuing BEN shares at 9.3x our FY 26 (Sep.) adj. EPS estimate of $2.37 (cut by $0.20) and at 10.6x our FY...
Research Alert: CFRA Keeps Hold Opinion On Shares Of United Parks & Resorts Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of United Parks & Resorts Inc.
May 26, 2025
03:00 PM EDT, 05/12/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $3 to $52, based on an EV/EBITDA multiple of 8x, in line with its three-year average forward multiple. We lift our 2025 EPS estimate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved